Effects of mifepristone on endometrial receptivity

Steroids

Volumn 68, Issue 10-13, 2003, Pages 1069-1075

  Danielsson, Kristina Gemzell ^a   Marions, Lena ^a   Bygdeman, Marc ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antiprogestin; Contraception; Endometrial receptivity; Female reproductive tract; Mifepristone; Steroid

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ESTROGEN; ESTRONE GLUCURONIDE; INTEGRIN; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; MIFEPRISTONE; PLACENTA PROTEIN 14; PREGNANEDIOL; PROGESTERONE; PROGESTERONE RECEPTOR; PROSTAGLANDIN; SOMATOMEDIN BINDING PROTEIN 1; TESTOSTERONE 17BETA DEHYDROGENASE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

CONFERENCE PAPER; CONTRACEPTION; CYTOPLASM; DOSE RESPONSE; DRUG EFFECT; ELECTRON MICROSCOPY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; LUTEAL PHASE; MENSTRUAL CYCLE; MORPHOLOGY; NONHUMAN; OVULATION; PINOPODE; PREGNANCY RATE; RECEPTIVE FIELD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE TUBE;

EID: 0346366914     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(03)00131-4     Document Type: Conference Paper

References (61)

1. Navot D., Scott R.T., Droesch K., Veeck L.L., Liu H.C., Rosenwaks Z. The window of embryo transfer and the efficiency of human conception in vitro. Fertil. Steril. 55:1991;114-118.
2. Swahn M.L., Johannisson E., Daniore V., de la Torre B., Bygdeman M. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium. Hum. Reprod. 3:1988;915-921.
3. Kazem R., Messinis L.E., Fowler P., Groome N.P., Knight P.G., Templeton A.A. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women. Hum. Reprod. 11:1996;2585-2590.
4. Batista M.C., Cartledge T.P., Zellmer A.W., Nieman L.K., Merriam G.R., Loriaux D.L. Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation. J. Clin. Endocrinol. Metab. 74:1992;565-570.
5. Spitz I.M., Croxatto H.B., Lahteenmaki P., Heikinheimo O., Bardin C.W. Effect of mifepristone on inhibition of ovulation and induction of luteolysis. Hum. Reprod. 9(Suppl. 1):1994;69-76.
6. Marions L., Hultenby K., Lindell I., Sun X., Stabi B., Gemzell Danielsson K. Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstet. Gynecol. 100:2002;65-71.
7. Nayak N.R., Ghosh D., Lasley B.L., Sengupta J. Anti-implantation activity of luteal phase mifepristone administration is not mimicked by prostaglandin synthesis inhibitor or prostaglandin analogue in the rhesus monkey. Contraception. 55:1997;103-114.
8. Ghosh D., Nayak N.R., Sengupta J. Effect of follicular phase administration of mifepristone (RU486) on blastocyst implantation in the rhesus monkey. Contraception. 56:1997;117-122.
9. Findlay J.K., Colvin N., Swaney J., Doughton B. Prostaglandin F and 13,14-dihydro-15-keto prostaglandin F in the endometrium and uterine flushings of sheep before implantation. J. Reprod. Fertil. 68:1983;343-349.
10. Zegers-Hochschild F., Altieri E. Luteal estrogen is not required for the establishment of pregnancy in the human. J. Assist. Reprod. Genet. 12:1995;224-228.
11. Edgar D.H., James G.B., Mills J.A. Steroid secretion by human early embryos in culture. Hum. Reprod. 8:1993;277-278.
12. Critchley H.O., Tong S., Cameron S.T., Drudy T.A., Kelly R.W., Baird D.T. Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo. J. Reprod. Fertil. 115:1999;389-395.
13. Gemzell-Danielsson K., Svalander P., Swahn M.L., Johannisson E., Bygdeman M. Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase. Hum. Reprod. 9:1994;2398-2404.
14. Cameron S.T., Critchley H.O., Thong K.J., Buckley C.H., Williams A.R., Baird D.T. Effects of daily low dose mifepristone on endometrial maturation and proliferation. Hum. Reprod. 11:1996;2518-2526.
15. Ghosh D., Kumar P.G., Sengupta J. Effect of early luteal phase administration of mifepristone (RU486) on leukaemia inhibitory factor, transforming growth factor beta and vascular endothelial growth factor in the implantation stage endometrium of the rhesus monkey. J. Endocrinol. 157:1998;115-125.
16. Lalitkumar P.G., Sengupta J., Karande A.A., Ghosh D. Placental protein 14 in endometrium during menstrual cycle and effect of early luteal phase mifepristone administration on its expression in implantation stage endometrium in the rhesus monkey. Hum. Reprod. 13:1998;3478-3486.
17. Qiu X., Sun X., Christow A., Ståbi B., Gemzell-Danielsson K. The effect of mifepristone on the expression of insuline-like growth factor binding protein-1, prolactin and progesterone receptor mRNA and protein during the implantation phase in human endometrium. Mol. Hum. Reprod. 8:2002;998-1004.
18. Rutanen E.M., Koistinen R., Sjoberg J., Julkunen M., Wahlstrom T., Bohn H.et al. Synthesis of placental protein 12 by human endometrium. Endocrinology. 118:1986;1067-1071.
19. Swahn M.L., Bygdeman M., Cekan S., Xing S., Masironi B., Johannisson E. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium. Hum. Reprod. 5:1990;402-408.
20. Li T.C., Dockery P., Thomas P., Rogers A.W., Lenton E.A., Cooke I.D. The effects of progesterone receptor blockade in the luteal phase of normal fertile women. Fertil. Steril. 50:1988;732-742.
21. Slayden O.D., Nayak N.R., Burton K.A., Chwalisz K., Cameron S.T., Critchley H.O.et al. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. J. Clin. Endocrinol. Metab. 86:2001;2668-2679.
22. Brenner R.M., Slayden O.D. Oestrogen action in the endometrium and oviduct of rhesus monkeys during RU486 treatment. Hum. Reprod. 9(Suppl 1):1994;82-97.
23. Johannisson E. Endometrial morphology during the normal cycle and under influence of contraceptive steroids. In: d'Arcangues C, Fraser IS, Newton JR, Odlind V, editors. Contraception and mechanisms of endometrial bleeding. Cambridge: Cambridge University Press; 1990:53-8.
24. King RJB, d'Arcangues C. Steroid hormone effects on uterine blood vessels. In: Alexander NJ, d'Arcangues C, editors. Steroid homones and uterine bleeding. Washington D.C.; 1992:25-36.
25. Johannisson E., Oberholzer M., Swahn M.L., Bygdeman M. Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486. Contraception. 39:1989;103-117.
26. Chwalisz K., Brenner R.M., Fuhrmann U.U., Hess-Stumpp H., Elger W. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium. Steroids. 65:2000;741-751.
27. Gemzell-Danielsson K., Westlund P., Johannisson E., Swahn M.L., Bygdeman M., Seppala M. Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum. Reprod. 11:1996;256-264.
28. Danielsson K.G., Swahn M.L., Bygdeman M. The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase - an immunohistochemical study. Hum. Reprod. 12:1997;1293-1297.
29. Garcia E., Bouchard P., De Brux J., Berdah J., Frydman R., Schaison G.et al. Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J. Clin. Endocrinol. Metab. 67:1988;80-87.
30. Psychoyos A, Martel D. Embryo-endometrial interactions at implantation. In: Edwards RG, Purdy JM, Steptoe PC, editors. Implantation of the human embryo. London: Academic Press; 1985. p.195-210.
31. Nikas G., Drakakis P., Loutradis D., Mara-Skoufari C., Koumantakis E., Michalas S.et al. Uterine pinopodes as markers of the 'nidation window' in cycling women receiving exogenous oestradiol and progesterone. Hum. Reprod. 10:1995;1208-1213.
32. Stavreus-Evers A., Nikas G., Sahlin L., Eriksson H., Landgren B.M. Formation of pinopodes in human endometrium is associated with the concentrations of progesterone and progesterone receptors. Fertil. Steril. 76:2001;782-791.
33. Acosta A.A., Elberger L., Borghi M., Calamera J.C., Chemes H., Doncel G.F.et al. Endometrial dating and determination of the window of implantation in healthy fertile women. Fertil. Steril. 73:2000;788-798.
34. Bentin-Ley U., Sjogren A., Nilsson L., Hamberger L., Larsen J.F., Horn T. Presence of uterine pinopodes at the embryo-endometrial interface during human implantation in vitro. Hum. Reprod. 14:1999;515-520.
35. Das S.K., Wang X.N., Paria B.C., Damm D., Abraham J.A., Klagsbrun M.et al. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development. 120:1994;1071-1083.
36. Stavreus-Evers A., Aghajanova L., Brismar H., Eriksson H., Landgren B.M., Hovatta O. Co-existence of heparin-binding epidermal growth factor-like growth factor and pinopodes in human endometrium at the time of implantation. Mol. Hum. Reprod. 8:2002;765-769.
37. Gemzell-Danielsson K., Hamberg M. The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2 alpha concentrations. Hum. Reprod. 9:1994;1626-1630.
38. Marions L., Danielsson K.G. Expression of cyclo-oxygenase in human endometrium during the implantation period. Mol. Hum. Reprod. 5:1999;961-965.
39. Cameron S.T., Critchley H.O., Buckley C.H., Kelly R.W., Baird D.T. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation. Fertil. Steril. 67:1997;1046-1053.
40. Lessey B.A., Damjanovich L., Coutifaris C., Castelbaum A., Albelda S.M., Buck C.A. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle. J. Clin. Invest. 90:1992;188-195.
41. Lessey B.A., Castelbaum A.J., Sawin S.W., Buck C.A., Schinnar R., Bilker W.et al. Aberrant integrin expression in the endometrium of women with endometriosis. J. Clin. Endocrinol. Metab. 79:1994;643-649.
42. Simon C., Valbuena D., Krussel J., Bernal A., Murphy C.R., Shaw T.et al. Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium. Fertil. Steril. 70:1998;896-906.
43. Marions L., Gemzell Danielsson K., Bygdeman M. The effect of antiprogestin on integrin expression in human endometrium: an immunohistochemical study. Mol. Hum. Reprod. 4:1998;491-495.
44. Puri C.P., Katkam R.R., Sachdeva G., Patil V., Manjramkar D.D., Kholkute S.D. Endometrial contraception: modulation of molecular determinants of uterine receptivity. Steroids. 65:2000;783-794.
45. Stewart C.L., Kaspar P., Brunet L.J., Bhatt H., Gadi I., Kontgen F.et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 359:1992;76-79.
46. Chen H.F., Shew J.Y., Ho H.N., Hsu W.L., Yang Y.S. Expression of leukemia inhibitory factor and its receptor in preimplantation embryos. Fertil. Steril. 72:1999;713-719.
47. Delage G., Moreau J.F., Taupin J.L., Freitas S., Hambartsoumian E., Olivennes F.et al. In-vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women. Hum. Reprod. 10:1995;2483-2488.
48. Smotrich D.B., Stillman R.J., Widra E.A., Gindoff P.R., Kaplan P., Graubert M.et al. Immunocytochemical localization of growth factors and their receptors in human pre-embryos and Fallopian tubes. Hum. Reprod. 11:1996;184-190.
49. Lai Y.M., Wang H.S., Lee C.L., Lee J.D., Huang H.Y., Chang F.H.et al. Insulin-like growth factor-binding proteins produced by Vero cells, human oviductal cells and human endometrial cells and the role of insulin-like growth factor-binding protein-3 in mouse embryo co-culture systems. Hum. Reprod. 11:1996;1281-1286.
50. Christow A., Sun X., Gemzell-Danielsson K. Effect of mifepristone and levonorgestrel on expression of steroid receptors in the human Fallopian tube. Mol. Hum. Reprod. 8:2002;333-340.
51. Mahmood T., Saridogan E., Smutna S., Habib A.M., Djahanbakhch O. The effect of ovarian steroids on epithelial ciliary beat frequency in the human Fallopian tube. Hum. Reprod. 13:1998;2991-2994.
52. Ghosh D., Kumar P.G., Sengupta J. Early luteal phase administration of mifepristone inhibits preimplantation embryo development and viability in the rhesus monkey. Hum. Reprod. 12:1997;575-582.
53. Messinis I.E., Templeton A. The effect of the antiprogestin mifepristone (RU 486) on maturation and in-vitro fertilization of human oocytes. Br. J. Obstet. Gynaecol. 95:1988;592-595.
54. Wolf J.P., Chillik C.F., Dubois C., Ulmann A., Baulieu E.E., Hodgen G.D. Tolerance of perinidatory primate embryos to RU 486 exposure in vitro and in vivo. Contraception. 41:1990;85-92.
55. Gemzell-Danielsson K., Swahn M.L., Svalander P., Bygdeman M. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Hum. Reprod. 8:1993;870-873.
56. Ghosh D., Sengupta J. Anti-nidatory effect of a single, early post-ovulatory administration of mifepristone (RU 486) in the rhesus monkey. Hum. Reprod. 8:1993;552-558.
57. Marions L., Danielsson K.G., Swahn M.L., Bygdeman M. Contraceptive efficacy of low doses of mifepristone. Fertil. Steril. 70:1998;813-816.
58. Marions L., Viski S., Danielsson K.G., Resch B.A., Swahn M.L., Bygdeman M.et al. Contraceptive efficacy of daily administration of 0.5 mg mifepristone. Hum. Reprod. 14:1999;2788-2790.
59. Glasier A., Thong K.J., Dewar M., Mackie M., Baird D.T. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N. Engl. J. Med. 327:1992;1041-1044.
60. Webb A.M., Russell J., Elstein M. Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception. BMJ. 305:1992;927-931.
61. WHO. Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Task Force on Postovulatory Methods of Fertility Regulation. Lancet 1999;353:697-702.